On Anisodamine continuous infusion treatment of abdominal pain 28 cases of allergic purpura.docVIP

 PAGE \* MERGEFORMAT 8 On Anisodamine continuous infusion treatment of abdominal pain 28 cases of allergic purpura [Paper Keywords] Anisodamine, allergic purpura, abdominal pain [Abstract] Objective: To investigate anisodamine continuous infusion treatment of the effect of abdominal purpura Methods: Both groups were given conventional treatment, observation group received Anisodamine, according to the degree of abdominal pain to 3 ~ 5 mg / h speed with syringe pump infusion, and then increase 1 mg / h until pain relief, and then dose reduced to 0.5 mg / h, 24 h withdrawal pump to maintain the control group was given anisodamine 10 mg, 50 mg severe were given temporary intramuscular pethidine ease the pain. Results: The time for complete remission of abdominal pain (9.7 + -5.9) d, significantly less than the control group (15.1 + -7.2) d, P lt;0.01. Conclusion: anisodamine continued to ease administration of micro-pump abdominal pain, allergic purpura easy to adjust the dose, the role of continuous, safe and effective. Henoch-Schonlein purpura is a systemic capillary allergic disease, more common in children and young people, divided into cutaneous, joint type, abdominal, renal and mixed. Abdominal purpura is a common one, and more mixed with the skin there to paroxysmal abdominal pain as the main clinical manifestations, many patients with severe abdominal pain, long duration, usually not effective analgesic drugs I Division in June 2005 - June 2008 using micro-injection pump Anisodamine low-dose continuous infusion into the abdominal pain, allergic purpura, 32 cases achieved good effect, are reported as follows: 1 Materials and Methods 1.1 General Information June 2005 - June 2008, to close the hospital accompanied by abdominal pain or a mixture of patients with allergic purpura 54 cases, 35 males and 19 females, aged 14 to 45 years, mean 22.6 years old. There are incentives to be found in 25 cases, of which the upper respiratory tract infec